AQUESTIVE THERAPEUTICS INC (AQST) Stock Analyst Earnings Estimates
NASDAQ:AQST - Nasdaq - US03843E1047 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 47.68M -6.20% | 50.583M 6.09% | 57.561M 13.80% | 45.961M -20.15% | 69.688M 51.62% | 99.858M 43.29% | 161.21M 61.44% | 233.99M 45.15% | 356.66M 52.43% | 532.59M 49.33% | 678.15M 27.33% | |
| EBITDA YoY % growth | -39.68M -25.09% | -13.757M 65.33% | -30.053M -118.46% | -52.65M -75.19% | -41.582M 21.02% | 3.927M 109.44% | 36.618M 832.47% | 82.365M 124.93% | 170.85M 107.43% | 217.16M 27.11% | N/A | |
| EBIT YoY % growth | -42.07M -21.31% | -15.102M 64.10% | -30.771M -103.75% | -59.578M -93.62% | -60.626M -1.76% | -37.025M 38.93% | 3.4M 109.18% | 49.64M 1,360.00% | 101.54M 104.55% | 162.69M 60.22% | 284.99M 75.17% | |
| Operating Margin | -88.23% | -29.86% | -53.46% | -129.63% | -87.00% | -37.08% | 2.11% | 21.21% | 28.47% | 30.55% | 42.02% | |
| EPS YoY % growth | -1.14 23.49% | -0.36 68.42% | -0.52 -44.44% | -0.74 -41.88% | -0.65 11.98% | -0.32 51.31% | -0.03 90.32% | 0.24 900.00% | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 -472.32% | -0.16 -24.23% | -0.16 13.21% | -0.20 17.83% | 0.02 110.69% | 0.02 111.37% | 0.02 109.28% |
| Revenue Q2Q % growth | 11.546M -42.55% | 12.439M -8.15% | 13.063M 21.38% | 11.832M 35.69% | 24.493M 112.13% | 24.546M 97.33% | 25.861M 97.97% |
| EBITDA Q2Q % growth | -11.254M -2,509.85% | -11.411M -47.84% | -13.179M -2.48% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.113M -25,759.18% | -12.656M -52.67% | -13.067M 3.77% | -17.748M 8.35% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.24 -41.18% | -0.17 | -0.07 | -38.41% |
| Q4 2024 Q2Q % growth | -0.19 -72.73% | -0.14 | -0.05 | -37.26% |
| Q3 2024 Q2Q % growth | -0.13 -333.33% | -0.13 | 0.00 | -0.62% |
| Q2 2024 Q2Q % growth | -0.03 70.00% | -0.13 | 0.10 | 76.28% |
| Q1 2024 Q2Q % growth | -0.17 -41.67% | -0.08 | -0.09 | -102.44% |
| Q4 2023 Q2Q % growth | -0.11 52.17% | -0.08 | -0.03 | -34.80% |
| Q3 2023 Q2Q % growth | -0.03 86.96% | -0.12 | 0.09 | 74.02% |
| Q2 2023 Q2Q % growth | -0.10 72.22% | -0.12 | 0.02 | 16.92% |
| Q1 2023 Q2Q % growth | -0.12 62.50% | -0.19 | 0.07 | 37.75% |
| Q4 2022 Q2Q % growth | -0.23 39.47% | -0.24 | 0.01 | 2.30% |
| Q3 2022 Q2Q % growth | -0.23 37.84% | -0.32 | 0.09 | 27.73% |
| Q2 2022 Q2Q % growth | -0.36 -9.09% | -0.37 | 0.01 | 1.96% |
| Q1 2022 Q2Q % growth | -0.32 21.95% | -0.42 | 0.10 | 23.11% |
| Q4 2021 Q2Q % growth | -0.38 36.67% | -0.48 | 0.10 | 20.31% |
| Q3 2021 Q2Q % growth | -0.37 24.49% | -0.46 | 0.09 | 19.39% |
| Q2 2021 Q2Q % growth | -0.33 -371.43% | -0.45 | 0.12 | 26.13% |
| Q1 2021 Q2Q % growth | -0.41 16.33% | -0.43 | 0.02 | 5.64% |
| Q4 2020 Q2Q % growth | -0.60 -25.00% | -0.27 | -0.33 | -126.24% |
| Q3 2020 Q2Q % growth | -0.49 9.26% | -0.47 | -0.02 | -5.35% |
| Q2 2020 Q2Q % growth | -0.07 91.46% | -0.44 | 0.37 | 84.11% |
| Q1 2020 Q2Q % growth | -0.49 16.95% | -0.48 | -0.01 | -3.09% |
| Q4 2019 Q2Q % growth | -0.48 | -0.40 | -0.08 | -20.66% |
| Q3 2019 Q2Q % growth | -0.54 | -0.71 | 0.17 | 23.64% |
| Q2 2019 Q2Q % growth | -0.82 | -0.64 | -0.18 | -28.97% |
| Q1 2019 Q2Q % growth | -0.59 | -0.52 | -0.07 | -14.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 8.72M -27.65% | 12.475M | -3.755M | -30.10% |
| Q4 2024 Q2Q % growth | 10.762M -2.15% | 13.345M | -2.583M | -19.36% |
| Q3 2024 Q2Q % growth | 13.542M 18.70% | 12.937M | 605K | 4.68% |
| Q2 2024 Q2Q % growth | 20.099M 51.79% | 12.628M | 7.471M | 59.16% |
| Q1 2024 Q2Q % growth | 12.053M 8.25% | 12.508M | -455K | -3.64% |
| Q4 2023 Q2Q % growth | 10.998M 2.98% | 11.864M | -866K | -7.30% |
| Q3 2023 Q2Q % growth | 11.409M -0.45% | 11.744M | -335K | -2.85% |
| Q2 2023 Q2Q % growth | 13.241M -0.22% | 11.232M | 2.009M | 17.89% |
| Q1 2023 Q2Q % growth | 11.134M -9.26% | 10.136M | 998K | 9.85% |
| Q4 2022 Q2Q % growth | 10.68M -3.61% | 10.625M | 55K | 0.52% |
| Q3 2022 Q2Q % growth | 11.46M -13.77% | 11.258M | 202K | 1.79% |
| Q2 2022 Q2Q % growth | 13.27M -13.55% | 10.784M | 2.486M | 23.05% |
| Q1 2022 Q2Q % growth | 12.27M 10.34% | 10.313M | 1.957M | 18.98% |
| Q4 2021 Q2Q % growth | 11.08M 54.97% | 9.549M | 1.531M | 16.03% |
| Q3 2021 Q2Q % growth | 13.29M 60.90% | 11.234M | 2.056M | 18.30% |
| Q2 2021 Q2Q % growth | 15.35M -29.20% | 9.665M | 5.685M | 58.82% |
| Q1 2021 Q2Q % growth | 11.12M 26.80% | 9.147M | 1.973M | 21.57% |
| Q4 2020 Q2Q % growth | 7.15M -56.46% | 6.377M | 773K | 12.12% |
| Q3 2020 Q2Q % growth | 8.26M -33.49% | 8.897M | -637K | -7.16% |
| Q2 2020 Q2Q % growth | 21.68M 94.79% | 8.941M | 12.739M | 142.48% |
| Q1 2020 Q2Q % growth | 8.77M -30.62% | 10.274M | -1.504M | -14.64% |
| Q4 2019 Q2Q % growth | 16.42M | 16.158M | 262K | 1.62% |
| Q3 2019 Q2Q % growth | 12.42M | 10.172M | 2.248M | 22.10% |
| Q2 2019 Q2Q % growth | 11.13M | 9.367M | 1.763M | 18.82% |
| Q1 2019 Q2Q % growth | 12.64M | 11.822M | 818K | 6.92% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.21% | 0% | -7.96% |
| Revenue | 0% | -6.99% | 0% | -9.15% |